Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Filana Therapeutics, Inc.
Market Cap
$41.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.63M
Interest Coverage Ratio
1146.00x
TTM Avg
576.00x
3Y Avg
576.00x
5Y Avg
576.00x
Market Cap
$44.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.31M
Interest Coverage Ratio
-10.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.50M
Interest Coverage Ratio
N/A
TTM Avg
53.13x
3Y Avg
53.13x
5Y Avg
53.13x
Market Cap
$38.52M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$44.98M
Interest Coverage Ratio
-11.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $41.71M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $42.86M | -8.80x | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.91M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.63M | 1146.00x | 576.00x | 576.00x | 576.00x |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.29M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.31M | -10.91x | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $44.50M | N/A | 53.13x | 53.13x | 53.13x |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | -0.13x | 0.53x | 0.64x | 0.43x |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.98M | -11.50x | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $38.41M | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.00
Current Ratio
2.08
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
